KorGene™ is a market leader in developing targeted, molecular diagnostics focused on improving clinical and economic outcomes.
KorGene was founded for the purpose of developing diagnostics to combat the global epidemic of antibiotic resistance, specifically to create test panels and a technology platform that enables providers to make more informed decisions on prescribing antibiotics.
CAP#: 8779637
CLIA#: 39D2166771